News

Final adoption of the opinion is expected from the European Commission later this year and subject to it being finally granted, the orphan drug status would trigger a

The treatment and enrollment in these studies is expected to restart after approval by the local regulatory authorities and ethics committees. The announcement follows a decision by the

The regulator has also advised manufacturers of liquid Vitamin D supplements that droppers accompanying these products should be clearly and accurately marked for 400 international units (IU). In

Brocacef holds stakes in companies from the field of homecare, blistering, formulation and the distribution of non-prescription products with total revenues of around EUR1b. In turn, Celesio receives

Stacked Graphene Platelet Nanofibers are grown via a patented process that decomposes carbon containing gases in the presence of metal catalyst particles, reported Cambridge Network. Strem’s nanomaterials product

Eisai Machinery and Crest Solutions said that the PharmaMarker system has been developed to meet the new coding and traceability regulations by coding, verifying and tracking up to

TxCell is now preparing a Phase I/IIa clinical study with TXRAD for the treatment of patients with moderate to severe Rheumatoid Arthritis. The clinical trial application should be

The manufacturing alliance is expected to allow ISP and Vivimed to jointly market specific products used in sprays and lotions that include UVA and UVB protective properties. Under

Currently CDI has validated a panel of cell-based cytotoxicity assays from Promega that use CDI’s human induced pluripotent stem (iPS) cell-derived iCell Cardiomyocytes. CDI and its pharmaceutical collaborators